ArticleCancer immunology, immunotherapy : CII2021

Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy.

Jessica Wenthe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.